Concepedia

Publication | Closed Access

Phase I trial of orally administered CEP-701, a novel neurotrophin receptor-linked tyrosine kinase inhibitor

DOI

94

Citations

24

References

2004

Year

John L. Marshall, Hedy L. Kindler, John F. Deeken, Pankaj Bhargava, Nicholas J. Vogelzang, Naiyer A. Rizvi, Taina Luhtala, Stacy Boylan, Margaret S. Dordal, Philmore Robertson,
Investigational New Drugs

References

YearCitations

Page 1